Identification of E2F1 as a positive transcriptional regulator for δ-catenin
- 2 May 2008
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 369 (2) , 414-420
- https://doi.org/10.1016/j.bbrc.2008.02.069
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA111891)
- U.S. Department of Defense (W81XWH-05-1-0028)
- Ministry of Health and Welfare
This publication has 26 references indexed in Scilit:
- Androgen Receptor– and E2F-1–Targeted Thymoquinone Therapy for Hormone-Refractory Prostate CancerCancer Research, 2007
- Elevated E2F1 Inhibits Transcription of the Androgen Receptor in Metastatic Hormone-Resistant Prostate CancerCancer Research, 2006
- Presenilin-1 D257A and D385A Mutants Fail to Cleave Notch in Their Endoproteolyzed Forms, but Only Presenilin-1 D385A Mutant Can Restore Its γ-Secretase Activity with the Compensatory Overexpression of Normal C-terminal FragmentJournal of Biological Chemistry, 2005
- p150Sal2 Is a p53-Independent Regulator of p21WAF1/CIPMolecular and Cellular Biology, 2004
- Notch Signaling in CancerCancer Biology & Therapy, 2002
- The p107 tumor suppressor induces stable E2F DNA binding to repress target promotersOncogene, 2001
- Identification and localization of a neurally expressed member of the plakoglobin/armadillo multigene familyDifferentiation, 1997
- Functional interaction of β-catenin with the transcription factor LEF-1Nature, 1996
- Physical interaction between a novel domain of the receptor Notch and the transcription factor RBP-Jκ/Su(H)Current Biology, 1995
- Loss of heterozygosity of the retinoblastoma and adenomatous polyposis susceptibility gene loci and in chromosomes 10p, 10q and 16q in human prostate cancerBritish Journal of Urology, 1994